Breaking News

Vibe coding: Game-changer or risky business?Alone in Gaza: Genocide leaves Palestinian man without family or a homeUS sanctions leave Iranians facing flight cancellations and soaring costsRubio presses Lebanon on confiscation of weapons from HezbollahVibe coding: Game-changer or risky business?Alone in Gaza: Genocide leaves Palestinian man without family or a homeUS sanctions leave Iranians facing flight cancellations and soaring costsRubio presses Lebanon on confiscation of weapons from Hezbollah

Monopar Therapeutics director Christopher Starr sells shares worth $659k

Investing.comWire Service

Published: Oct 12, 2026, 12:01 AMUpdated: Oct 12, 2026, 12:37 AM

Monopar Therapeutics director Christopher Starr sells shares worth $659k

Monopar Therapeutics director Christopher Starr sells shares worth $659k

Monopar Therapeutics director Christopher Starr sells shares worth $659k

Read the original report from Investing.com.

#finance #breakingnews #liveupdate

Related Articles

Crowdstrike president and CEO George Kurtz sells $5.15M in stock

Crowdstrike president and CEO George Kurtz sells $5.15M in stock

By Investing.com-Oct 16

Talos Energy 10% owner sells $51.8m in shares

Talos Energy 10% owner sells $51.8m in shares

By Investing.com-Oct 16